ID
11719
Beschreibung
The purpose of this study is to compare the safety of two different dose regimens of unfractionated heparin (UFH) during a percutaneous coronary intervention (PCI) procedure in patients with UA (unstable angina)/NSTEMI (non ST segment elevation myocardial infarction) who have been initially treated with fondaparinux. https://clinicaltrials.gov/ct2/show/NCT00790907
Link
https://clinicaltrials.gov/ct2/show/NCT00790907
Stichworte
Versionen (1)
- 28.07.15 28.07.15 -
Hochgeladen am
28. Juli 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility FUTURA/OASIS 8 Acute Coronary Syndrome NCT00790907
Eligibility Criteria
- StudyEvent: ODM
Beschreibung
Exclusion Criteria
Beschreibung
Age < 21 years
Datentyp
boolean
Alias
- UMLS CUI-1
- C0001779
Beschreibung
Any contraindication to UFH
Datentyp
boolean
Alias
- UMLS CUI-1
- C2825026
- UMLS CUI-2
- C0522473
Beschreibung
Any contraindication to fondaparinux
Datentyp
boolean
Alias
- UMLS CUI-1
- C1098510
- UMLS CUI-2
- C0522473
Beschreibung
Contraindication for angiography or PCI at baseline
Datentyp
boolean
Alias
- UMLS CUI-1
- C1532338
- UMLS CUI-2
- C0522473
Beschreibung
Contraindication for angiography at baseline
Datentyp
boolean
Alias
- UMLS CUI-1
- C0085532
- UMLS CUI-2
- C0522473
Beschreibung
refractory or recurrent angina associated with dynamic ST-deviation
Datentyp
boolean
Alias
- UMLS CUI-1
- C0002962
Beschreibung
heart failure
Datentyp
boolean
Alias
- UMLS CUI-1
- C0018801
Beschreibung
life-threatening arrhythmias
Datentyp
boolean
Alias
- UMLS CUI-1
- C0085612
Beschreibung
hemodynamic instability
Datentyp
boolean
Alias
- UMLS CUI-1
- C0948268
Beschreibung
Subjects already receiving treatment with enoxaparin for treatment of the qualifying events
Datentyp
boolean
Alias
- UMLS CUI-1
- C0206460
Beschreibung
Subjects already receiving treatment with LMWH for treatment of the qualifying events
Datentyp
boolean
Alias
- UMLS CUI-1
- C3536766
Beschreibung
Subjects already receiving treatment with bivalirudin for treatment of the qualifying events
Datentyp
boolean
Alias
- UMLS CUI-1
- C0168273
Beschreibung
Subjects already receiving treatment with UFH for treatment of the qualifying events
Datentyp
boolean
Alias
- UMLS CUI-1
- C2825026
Beschreibung
Hemorrhagic stroke within the last 12 months.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0559159
Beschreibung
Indication for anti-coagulation other than acute coronary syndrome (ACS) during the index hospitalization.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0003281
Beschreibung
Pregnancy or women of childbearing potential who are not using an effective method of contraception.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0549206
Beschreibung
Co-morbid condition with life expectancy less than 6 months.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0679247
Beschreibung
Currently receiving an experimental pharmacological agent.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0304229
Beschreibung
Revascularization procedure already performed for the qualifying event.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0027056
Beschreibung
Severe renal insufficiency (i.e., estimated creatinine clearance <20 ml/min)
Datentyp
boolean
Alias
- UMLS CUI-1
- C1533077
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: ODM
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)